Topical Methimazole as a New Treatment for Postinflammatory Hyperpigmentation: Report of the First Case

Behrooz Kasraee,Farhad Handjani,Amin Parhizgar,Gholamhosein R. Omrani,Mohammad Reza Fallahi,Mitra Amini,Mohammad Nikbakhsh,Christian Tran,Ambros Hügin,Olivier Sorg,Jean-Hilaire Saurat

Topical Methimazole as a New Treatment for Postinflammatory Hyperpigmentation: Report of the First Case

2005

Behrooz Kasraee
Farhad Handjani
Amin Parhizgar
Gholamhosein R. Omrani
Mohammad Reza Fallahi
Mitra Amini
Mohammad Nikbakhsh
Christian Tran
Ambros Hügin
Olivier Sorg
Jean-Hilaire Saurat

We have previously shown that the peroxidase inhibitor methimazole (1-methyl-2-mercapto imidazole; MMI) is a noncytotoxic inhibitor of melanin production in cultured B16 melanocytes. It was further de

Keywords:

Dermatology
Hyperpigmentation
Melanin
Antithyroid agent
Kojic acid
Pigmentation disorder
Peroxidase
Chemotherapy
Medicine
Postinflammatory hyperpigmentation
Methimazole

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations